FDA Brief

Recalls

When a product is unsafe or breaks the rules, the company pulls it back and FDA classes the recall. Class I could cause serious harm or death. Class II could cause temporary harm. Class III is unlikely to hurt anyone.

5,412 recalls in the last 12 months. Newest first.

ReportedClassFirmProduct and reason
Dec 10, 2025 Class II Hale inc
Food
Lotsa Pasta International Food Shop Fresh Basil Infused Olive Oil, Net Wt. 12 oz. (375ml), packaged in a glass bottle, UPC 736211448316, packed 12 bottles per case
Potential to be contaminated with Clostridium botulinum. Products manufactured without an approved process filed.
FDA notice H-0241-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
WeCare, Zinc Oxide Ointment, Net Wt. 15 oz/425 g, Manuactured for: Dynarex Corporation, 11 Dynarex Drive, Middletown, NY 10941, Made in India, NDC 67777-223-05.
cGMP deviations
FDA notice D-0205-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Dynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for: Dynarex Corporation, 16 Glenshaw Street, Orangeburg, NY 10962, UPC 61784128016.
cGMP deviations
FDA notice D-0204-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, USA, NDC 69396-087-55.
cGMP deviations
FDA notice D-0211-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Nivagen, Zinc Oxide Ointment, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA Made in India, NDC 75834-170-01.
cGMP deviations
FDA notice D-0208-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319.
cGMP deviations
FDA notice D-0201-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01.
cGMP deviations
FDA notice D-0210-2026
Dec 10, 2025 Class II Cipla Limited
Drug
Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097…
Failed Stability Specifications: Observed OOS results: eg results for colour index
FDA notice D-0197-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, Made in India, NDC 75834-170-02.
cGMP deviations
FDA notice D-0209-2026
Dec 10, 2025 Class III Teva Pharmaceuticals USA, Inc
Drug
Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ …
Defective Container - A defect in the side-seal which allows leakage of product.
FDA notice D-0198-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Dynashield, 4 oz cream (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10852, USA, Made in India, NDC 67777-407-03.
cGMP deviations
FDA notice D-0207-2026
Dec 10, 2025 Class II Breckenridge Pharmaceutical, Inc.
Drug
Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC…
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
FDA notice D-0215-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04.
cGMP deviations
FDA notice D-0213-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Wecare Enema, 4.5 Fl Oz/133mL, Manufactured for: Dynarex Corporation, 11 Dynarex Corporation, MIddletown, NY 10941 USA, Made in India, NDC 67777-402-01.
cGMP deviations
FDA notice D-0203-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Dynashield Skin Protectant, Net Wt. 16 oz (453.6 g), Manufactured for: Dyrnarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, USA, Made in India, NDC 67777-407-04.
cGMP deviations
FDA notice D-0202-2026
Dec 10, 2025 Class II Breckenridge Pharmaceutical, Inc.
Drug
Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical Inc., Berkel…
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
FDA notice D-0216-2026
Dec 10, 2025 Class II Park Avenue Compounding
Drug
Phenylephrine HCI, 1000 mcg / 10 mL, 10 mL Total Volume, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110-2512, NDC 83863-0104-1.
CGMP Deviations
FDA notice D-0200-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt. 15 oz (425g), Made in India, Manufactured for: Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, NDC 75834-170-15.
cGMP deviations
FDA notice D-0206-2026
Dec 10, 2025 Class II Safecor Health, LLC
Drug
Haloperidol Lactate Injection, 5 mg/mL, 25 x 1 mL Single-Dose Vials, Sterile, Rx only, For Intramuscular Use Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26605. NDC: 67457-426-12 with Safecor Health …
Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.
FDA notice D-0214-2026
Dec 10, 2025 Class II Blossom Pharmaceuticals
Drug
Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (56.7 g), Distributed by: Trifecta Pharmaceuticals USA 101 NE, Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, NDC 69396-086-02.
cGMP deviations
FDA notice D-0212-2026
Dec 10, 2025 Class III Glenmark Pharmaceuticals Inc., USA
Drug
Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles, NDC-68462-878-30; (b) 100-count bottle, NDC-68462-878-01; (c) 500-count bottles, NDC-68462-878-05; Rx Only, Manu…
Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
FDA notice D-0199-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Continuous Glucose Monitor (CGM)
Distribution without premarket approval/clearance.
FDA notice Z-0770-2026
Dec 10, 2025 Class II Philips North America Llc
Device
IntelliVue MP70. Product Number: M8007A.
Potential issue where the IntelliVue monitors did not alarm.
FDA notice Z-0856-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Estrogen & Progesterone Test
Distribution without premarket approval/clearance.
FDA notice Z-0805-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Gut Microbiome Test Medium
Distribution without premarket approval/clearance.
FDA notice Z-0779-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Vaginal PH Test
Distribution without premarket approval/clearance.
FDA notice Z-0755-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Environmental Pollutants Profile Test
Distribution without premarket approval/clearance.
FDA notice Z-0758-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Sorbitol Intolerance Test
Distribution without premarket approval/clearance.
FDA notice Z-0797-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
IBS Test
Distribution without premarket approval/clearance.
FDA notice Z-0784-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Neurotransmitters XL
Distribution without premarket approval/clearance.
FDA notice Z-0791-2026
Dec 10, 2025 Class II Philips North America Llc
Device
IntelliVue Patient Monitor MX450. Product Number: 866062.
Potential issue where the IntelliVue monitors did not alarm.
FDA notice Z-0863-2026
Dec 10, 2025 Class II Aizu Olympus Co., Ltd.
Device
Olympus OER-Mini
Inform existing affected device customers about pertinent Warnings/Cautions, existing recommended maintenance schedules and that only properly trained personnel conduct repairs and maintenance.
FDA notice Z-0874-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Melatonin Test
Distribution without premarket approval/clearance.
FDA notice Z-0812-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Women s Hormone Test
Distribution without premarket approval/clearance.
FDA notice Z-0798-2026
Dec 10, 2025 Class II Philips North America Llc
Device
IntelliVue Patient Monitor MX750. Product Number: 866471.
Potential issue where the IntelliVue monitors did not alarm.
FDA notice Z-0868-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Fecal Occult Blood Test
Distribution without premarket approval/clearance.
FDA notice Z-0736-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Epstein-Barr Virus (EBV VCA & EBNA IgG) Test
Distribution without premarket approval/clearance.
FDA notice Z-0735-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Neurotransmitters Basic
Distribution without premarket approval/clearance.
FDA notice Z-0789-2026
Dec 10, 2025 Class II Philips North America Llc
Device
IntelliVue Patient Monitor MX550. Product Number: 866066.
Potential issue where the IntelliVue monitors did not alarm.
FDA notice Z-0865-2026
Dec 10, 2025 Class II Siemens Medical Solutions USA, Inc
Device
MAMMOMAT Revelation;
There were instances where the operator table was sold together with a bus-installation kit. The operator table is not intended and not released for bus installations as it was designed for stationary operation only.
FDA notice Z-0877-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
H pylori (Peptic ulcer) Test
Distribution without premarket approval/clearance.
FDA notice Z-0739-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Men s Hormone Test
Distribution without premarket approval/clearance.
FDA notice Z-0788-2026
Dec 10, 2025 Class II Aizu Olympus Co., Ltd.
Device
Olympus OER-Pro
Inform existing affected device customers about pertinent Warnings/Cautions, existing recommended maintenance schedules and that only properly trained personnel conduct repairs and maintenance.
FDA notice Z-0873-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Food Sensitivity Test Medium
Distribution without premarket approval/clearance.
FDA notice Z-0761-2026
Dec 10, 2025 Class II Accriva Diagnostics, Inc.
Device
Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE Whole Blood Microcoagulation System
Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling.
FDA notice Z-0880-2026
Dec 10, 2025 Class II Philips North America Llc
Device
IntelliVue Multi-Measurement Module X3. Product Number: 867030.
Potential issue where the IntelliVue monitors did not alarm.
FDA notice Z-0860-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Ovulation Test (5 tests)
Distribution without premarket approval/clearance.
FDA notice Z-0747-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Allergy & Food Intolerance Test
Distribution without premarket approval/clearance.
FDA notice Z-0802-2026
Dec 10, 2025 Class II GET TESTED INTERNATIONAL AB
Device
Pregnancy Test
Distribution without premarket approval/clearance.
FDA notice Z-0749-2026
Dec 10, 2025 Class II Philips North America Llc
Device
IntelliVue Patient Monitor MX400. Product Number: 866060.
Potential issue where the IntelliVue monitors did not alarm.
FDA notice Z-0862-2026